Neurogenic Orthostatic Hypotension
📧 Sign up to get email alerts when something new happens for Neurogenic Orthostatic Hypotension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-07Clinical Trial Results: Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients [EARLY_Phase 1]
Early-phase trial comparing midodrine to abdominal compression in autonomic failure patients assessing cardiovascular risk markers.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: CPAP for the Treatment of Supine Hypertension [NA]
This clinical trial update indicates that a study is recruiting to evaluate CPAP for the treatment of supine hypertension in autonomic failu…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Study in Subjects With Neurogenic Orthostatic Hypotension [Phase 2]
Clinical trial update for a Phase 2 study in subjects with Neurogenic Orthostatic Hypotension, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients [EARLY_Phase 1]
A Phase 1 clinical trial is evaluating midodrine versus abdominal compression for cardiovascular risk markers in autonomic failure, and the …
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy [Phase 3]
A Phase 3 trial update evaluating the efficacy and durability of Ampreloxetine for treating symptomatic neurogenic orthostatic hypotension i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms [NA]
This clinical trial update describes a Vanderbilt-led study evaluating accelerometer-based quantification of symptoms in neurogenic orthosta…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Natural History Study of Synucleinopathies
An update on an ongoing natural history study of synucleinopathies, currently recruiting participants, including Parkinson's disease and rel…
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: Controlled CO2 Inhalation in NOH [NA]
A clinical trial investigating controlled CO2 inhalation for neurogenic orthostatic hypotension has not yet begun recruiting. The sponsor is…
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: Hypercapnia in Orthostatic Hypotension [NA]
A University of Calgary-sponsored clinical trial is investigating hypercapnia in patients with orthostatic hypotension and neurogenic orthos…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: CO2 Rebreathing in nOH: A Proof-of-Concept Pilot Study [NA]
The clinical trial update reports a proof-of-concept pilot study on CO2 rebreathing for neurogenic orthostatic hypotension and autonomic fai…
-
CLINICAL_TRIALS trial_result · 2023-10-02Clinical Trial Update: Efficacy and Tolerance of Flucortac in Patients With Orthostatic Neurogenic Hypotension [Phase 4]
Phase 4 trial update reporting efficacy and tolerance of Flucortac in patients with neurogenic orthostatic hypotension.
-
CLINICAL_TRIALS trial_result · 2023-08-23Clinical Trial Update: Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension [Phase 4]
Phase 4 trial update showing sustained effect of droxidopa in symptomatic neurogenic orthostatic hypotension.
-
CLINICAL_TRIALS trial_result · 2022-09-26Clinical Trial Update: TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH) [Phase 2]
Phase 2 clinical trial update for TD-9855 in neurogenic orthostatic hypotension (nOH) completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-09-16Clinical Trial Update: Norepinephrine Transporter Blockade, Autonomic Failure (NETAF) [Phase 2]
Phase 2 clinical trial update for norepinephrine transporter blockade in neurogenic orthostatic hypotension has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2022-09-14Clinical Trial Update: Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure [Phase 3]
Phase 3 trial assessing ampRELOXetine (TD-9855) for symptomatic neurogenic orthostatic hypotension due to primary autonomic failure has comp…
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: Brain Perfusion & Oxygenation in Parkinson's Disease With NOH [Phase 4]
Phase 4 trial update on brain perfusion and oxygenation in Parkinson's disease with neurogenic orthostatic hypotension has completed.
-
FDA approval · 2021-11-01FDA Approved: DROXIDOPA — Original Application (Slate Run Pharmaceuticals, LLC)
The FDA approved the original application for droxidopa from Slate Run Pharmaceuticals, LLC, enabling its market authorization for treating …
-
FDA approval · 2021-04-28FDA Approved: DROXIDOPA — Original Application (Bionpharma Inc.)
FDA approved the original application for a generic version of droxidopa, with Bionpharma Inc. as the manufacturer. The drug is used to trea…
-
FDA approval · 2021-02-18FDA Approved: DROXIDOPA — Original Application (ScieGen Pharmaceuticals Inc)
FDA approved the original application for droxidopa from ScieGen Pharmaceuticals Inc to treat symptomatic neurogenic orthostatic hypotension…
-
FDA approval · 2021-02-18FDA Approved: DROXIDOPA — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic droxidopa (DROXIDOPA) under an Original Application (ANDA211726).
-
FDA approval · 2021-02-18FDA Approved: DROXIDOPA — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves the original application for droxidopa from Zydus Pharmaceuticals USA Inc., making a generic version of the drug available.
-
FDA approval · 2021-02-18FDA Approved: DROXIDOPA — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic droxidopa product under an original application (ANDA 211652).
-
FDA approval · 2021-02-18FDA Approved: DROXIDOPA — Original Application (Aurobindo Pharma Limited)
FDA approved a generic version of droxidopa under an Original Application (ANDA 214387) from Aurobindo Pharma Limited.
-
FDA approval · 2021-02-18FDA Approved: DROXIDOPA — Original Application (CivicaScript LLC)
FDA approved the original application for droxidopa (generic) by CivicaScript LLC to treat neurogenic orthostatic hypotension.
-
FDA approval · 2021-02-18FDA Approved: DROXIDOPA — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original application for droxidopa (DROXIDOPA) for Novadoz Pharmaceuticals LLC.